Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments - Fair Value Measurements, Additional Information (Details)

v3.19.1
Financial Instruments - Fair Value Measurements, Additional Information (Details)
3 Months Ended 12 Months Ended
Mar. 31, 2019
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2018
USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Payment of contingent consideration $ (2,400,000) $ (500,000)  
EBITDA metric, measurement component change affected by change in discount rate 2,300,000    
Carrying Value      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Long-term debt, fair value 1,520,000,000   $ 5,350,000,000
Estimated Fair Value      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Long-term debt, fair value $ 1,540,000,000    
Contingent Consideration, Adjusted EBITDA Performance Metric      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Percentage change in rate affecting component measurement (as a percent) 10.00%    
Mac Dermid      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Long-term contingent consideration (up to) $ 100,000,000    
Price performance metrics period     7 years
Long-term contingent consideration 60,000,000.0    
Mac Dermid | Contingent Consideration, Common Stock Performance Target      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Payment of contingent consideration 40,000,000.0    
Payment of contingent consideration, operating 30,900,000    
Payment of contingent consideration, financing 9,100,000    
Mac Dermid | Contingent Consideration, Adjusted EBITDA Performance Metric      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Expected future value of payments, target 1 0.0    
Expected future value of payments, target 2 30,000,000.0    
Expected future value of payments, target 3 $ 60,000,000.0    
Mac Dermid | Contingent Consideration, Adjusted EBITDA Performance Metric | Discount Rate      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
EBITDA related earnout include a discount rate (as a percent) 0.1050